We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Department of Quality Assurance, Laxminarayan Dev College of Pharmacy, Gujarat Technological University, Bholav, Bharuch – 392015, India
An essential component of the pharmaceutical Quality Management System (QMS), Correc-tive and Preventive Action (CAPA) supports companies in locating, examining, and resolving the underlying causes of quality-related issues. CAPA guarantees ongoing enhancements to production procedures, system performance, and product quality. The concept, goals, signifi-cance, protocols, regulations, and documentation of CAPA in the pharmaceutical sector are all explained in this article. Tools for root cause analysis, including Fishbone Diagram, FMEA, SPC, and Fault Tree Analysis, are also covered. CAPA enhances customer satisfaction, low-ers risks, and minimizes production failures while supporting regulatory compliance with FDA, ISO, ICH Q9, and ICH Q10 guidelines. An efficient CAPA system improves opera-tional effectiveness, stops problems from reoccurring and improves the pharmaceutical quality management system as a whole.
A crucial component of the pharmaceutical quality system, Corrective and Preventive Action (CAPA) is critical to the continual improvement of production procedures, product quality, and system performance. The interconnected procedures that make up a Quality Management System (QMS) are intended to direct and oversee an organization with a focus on quality. Continuous improvement is achieved by continuously assessing and improving the quality system, processes, and products to increase efficacy and efficiency. [6] By using quality policies, quality objectives, audit findings, data analysis, and CAPA activities, organizations are required to consistently improve the performance of their QMS. It provides a systematic and documented approach for identifying issues, investigating root causes, and implementing corrective or preventive measures. This structured process helps ensure thorough investigations, effective solutions, regulatory compliance, and supports ongoing improvement initiatives within the organization. [7] The International Organization for Standardization's (ISO) 9001:2000 continuous improvement approach is represented in CAPA. CAPA works as a quality improvement tool on a dual-loop system, one reactive and one proactive, and is a constant and reliable component of product, process, and quality system enhancement. The FDA defines the purpose of a CAPA procedure as: collecting and analysing information, identifying and investigating product and quality problems, and taking appropriate and effective corrective and/or preventive action to prevent their recurrence.
Definitions: [6] [7] [23]
Table 1: Difference between Corrective Actions and Preventive Actions: [19]
|
Corrective action |
Preventive action |
|
Actions taken to address and resolve an existing nonconformity, issue, or problem. |
Measures made to stop such concerns, nonconformities, or difficulties before they arise. |
|
Aims to prevent a problem or issue from recurring by addressing its underlying cause or source. |
Attempts to locate and get rid of possible sources or causes of issues before happen. |
|
Reactive in nature, implemented after an issue or nonconformity has occurred. |
Implemented in a proactive manner, usually prior to the occurrence of an issue or nonconformity. |
|
Prompted by an issue with quality, performance deviation, customer complaint, nonconformity, defect, or problem that has been found. |
Caused by examination, historical data, patterns, lessons discovered, risk assessment, evaluation, analysis, and possible hazards and possibilities. |
|
Focuses on identifying the root cause of the issue or nonconformity and implementing corrective action to deal with it successfully. |
Focuses on finding and putting into action preventative steps to get rid of or lessen possible sources of issues or nonconformities. |
Objective of CAPA:
In any industry, the primary goal of corrective action and preventative action (CAPA) is to identify the weakness, inconsistency, or errors and to carry out an investigation with appropriate measures to stop the issue from reoccurring. The corrective and preventive action subsystem's goals are to collect and evaluate data, find and look into issues with products and quality, and take appropriate and efficient corrective and/or preventative action to stop them from reoccurring. [21] [31] In order to effectively manage products and prevent their recurrence, quality issues, and device failures, it is crucial to verify or validate corrective and preventive actions, communicate corrective and preventive action activities to responsible individuals, provide relevant information for management review, and document these activities. The corrective and preventive action subsystem is one of the most crucial components of the quality system. CAPA identifies actions needed to correct the causes of identified problems and seeks to eliminate permanently the causes of problems that have a negative impact on systems, processes and products. [9] [7]
Importance of CAPA: [11] [4] [5]
Regulatory Guidelines: [4] [22] [30]
FDA 21 CFR 820.100(Devices) requires manufacturers to analyse quality data, investigate causes of nonconformities, and ensure actions prevent recurrence—implicitly applying risk.
FDA 21 CFR 211.192(Medicinal Products) requires thorough investigations for unexplained discrepancies, yield results, OOS results, or repeated failures.
EU GMP Part I, Chapter 1.4 & Chapter 8require manufacturers to have a system for detecting, investigating, and correcting quality defects based on risk management principles.
EU GMP Part II (ICH Q7) section 2.5 & 2.15require firms to investigate issues and implement corrective actions where appropriate.
ICH Q9(Quality Risk Management) and ICH Q10(Pharmaceutical Quality System) explicitly require risk-based decisions for CAPA escalation. Escalation decisions must be proportional to the level of risk posed to patients, product quality, and compliance.
CAPA procedures: [5] [7] [30]
Maintaining quality standards and fulfilling regulatory requirements depend significantly on an efficient Corrective Action and Preventive Action (CAPA) system. Organizations can utilize the CAPA method to detect difficulties, determine their root causes, implement corrective actions, and prevent similar problems from occurring in the future. In general, the procedure is carried out in six crucial steps.
Clearly defining and identifying the issue is the first step. The company has to determine exactly what went wrong and compile all relevant data. This involves determining the location of the issue, gathering information, and providing a thorough account of the circumstances. Before taking any action, adequate identification ensures that the problem is completely recognized.
The next stage after finding the issue is to assess how serious it is and decide whether any action is required. The company must assess how the problem might affect customers, products, processes, or the company as a whole. In this phase, the problem's risks are evaluated, and the significance of the issue is appropriately recorded.
An investigation strategy is created once the importance of acting is established. This strategy outlines who will be in charge, how the investigation will be conducted, and what resources will be needed. A documented process makes it easier to guarantee that the inquiry is thorough, systematic, and that no crucial information is missed.
The actual investigation to identify the problem's fundamental source occurs at this point. All potential reasons are thoroughly investigated and data is gathered. Finding the root cause of the problem rather than just concentrating on its symptoms is the primary goal. In order to successfully address the issue, any contributing components are also recognized in addition to the root cause.
An appropriate action plan is created based on the analysis's conclusions. The corrective steps required to address the current issue as well as preventative measures to stay clear of similar problems in the future are included in this plan. Updating records, altering processes or procedures, training staff, and putting monitoring systems or controls in place are all possible components of the strategy. Each task's responsibilities are also clearly assigned to particular people.
Verifying the efficacy of the steps taken is the last phase. The company must verify whether the CAPA process's goals have been effectively met. It should be verified that all necessary adjustments have been made, the issue has been fixed, and preventive measures are operating as intended. To make sure everyone is aware of the enhancements and new protocols, employee communication and training should also be examined. In order to prevent the same issue from happening again in the future, proper follow-up is essential.
Fig. no.1: Flow chart of the CAPA procedure
Root cause Analysis: [11] [17]
Effective root cause analysis is essential for successful CA because without it, corrective measures may be ineffective. Statistical methods include tools like Statistical Process Control (SPC), which uses Shewhart and Pareto charts, as well as regression analysis, which includes both linear and non-linear forms; additionally, the design of experiments (DOE) is used for variable studies and experimental models; visual representation techniques, such as circle graphs and scatter diagrams, are part of these methods; administrative reviews, on the other hand, entail process evaluation and quality discussions. For CA to be successful, root cause analysis is essential because without it, corrective actions could not work. Regression analysis, which includes both linear and non-linear variations, and Statistical Process Control (SPC), which makes use of Shewhart and Pareto charts, are examples of statistical methodologies. Additionally, variance studies and experimental models use the design of experiments (DOE). These approaches also include pictographic tools like scatter diagrams and circle graphs. Nonstatistical procedures, on the other hand, include administrative evaluations that include process evaluation and quality discussions. [9] Another important method for evaluating possible failure modes and their effects on product performance is Failure mode and effects analysis (FMEA). Fault tree analysis, a deductive approach, is used to graphically represent the causes of failures, especially in the analysis of complaints or deviations. Fishbone analysis, also known as the Ishikawa diagram, is a systematic approach to problem-solving that encourages group involvement and helps identify data for further analysis. The diagram classifies variables based on their potential impact and helps establish a control strategy. [3] A deductive method called fault tree analysis is used to graphically depict the reasons for failures, especially when analysing complaints or deviations.
Ishikawa diagram, or fishbone analysis: By illustrating the connection between effects and their causes, the Ishikawa diagram helps identify possible reasons of quality problems. It encourages group participation, a methodical approach to problem-solving, and the identification of data for additional study. The graphic aids in the establishment of a control strategy by categorizing factors according to their possible impact. For example, this approach can be especially useful in the pharmaceutical sector when examining batch failures, where it might identify individual elements that might have contributed to the issue. Problem analysis form: A problem analysis form can be used to record the specifics of the investigation, acting as a central location for gathering and attaching pertinent data, albeit its use is optional
Fig.no.2: Ishikawa diagram: Root cause analysis
Relation of CAPA with Quality Subsystem: [9] [31]
The CAPA system is a critical component of an effective QMS and it must maintain a close relationship with other quality subsystems. The ultimate goal of any regulated company must be to have a CAPA system that is compliant, effective and efficient. All relevant subsystems that may produce non-conformances must be part of the process. Internal processes encompass both non-conformance and in-conformance results, internal audits and assessments, management reviews and so on. External sources of CAPA process inputs are supplier audits and assessments, customer feedback and results from external audits and assessment such as regulatory agencies, ISO and so on. [34]
Fig.no.3: Quality subsystems of CAPA
Management system of CAPA: [4] [6]
CAPA refers to two distinct requirements for documented ‘Corrective Action’ and ‘Preventative Action’ procedures that should form part of your med tech Quality Management System. CAPA Management system and necessities of CAPA management system. Corrective Action and Preventive Action (CAPA) is a systematic approach designed to identify, resolve, and prevent issues such as deviations, nonconformities, and complaints. [7] CAPA enhances safety and product quality by reducing defective product risks, optimizing manufacturing processes, minimizing waste, lowering rework costs, and promoting continuous improvement. CAPA management drives continuous improvement in pharmaceutical companies. Systematic trend analysis and preventive measures strengthen the quality management system, ensuring compliance and operational excellence. [21]
Fig.no.4: CAPA management system
Documentation of CAPA: [8] [20] [35]
CAPA (Corrective and Preventive Action) documentation is a structured record-keeping process used to identify, investigate, and resolve issues, preventing their recurrence. It is essential for regulatory compliance (FDA, ISO 13485) and requires documenting the problem description, root cause investigation, action plans, implementation evidence, and effectiveness checks. Documentation of the root cause analysis, including methods like the "5 Whys" or fishbone diagrams. Records demonstrating that actions were implemented (e.g., training logs, updated procedures, work orders).
Fig.no.5: Documentation format of CAPA [8]
Conducting investigations and actions on time seems to be one of the most difficult tasks for organizations. It's commonly believed that everything is an individual incidence. In other cases, issues remain unfixed and are attributed to a single worker, a straightforward lab error, or the system's inability to prevent an issue from spreading to other lots, causing the incident to recur. Making sure it doesn't occur again is the highest standard for appropriate remediation. [17] After the ICH Q10 standard was introduced, CAPA was accepted as a new quality management instrument. According to the ICH Q10 document, which was adopted by the FDA in April 2009 as an industry guideline, a pharmaceutical Quality Management System (QMS) consists of four central elements:
Process performance and product quality monitoring
Corrective action and preventive actions
Change management
Management review of process performance and product quality.
According to the guideline, a pharmaceutical business must have a system in place to identify and assess non-conformances so that appropriate corrective and preventive measures can be taken. Information on non-conformances can come from a variety of sources, including complaints, variations, recalls, observations made during audits and inspections, and monitoring results. Finding the real root cause must be the goal of the system's examinations. Therefore, it is necessary to obtain a deeper understanding of both the process and the final product in order to make improvements. [22]
Advantages of CAPA: [6] [7]
Application of CAPA: [9] [11]
Pharmaceutical development- Product or process variability is explored. CAPA methodology is useful where corrective actions and preventive actions are incorporated into the iterative design and development process.
Technology transfer- CAPA can be used as an effective system for feedback, feed forward and continual improvement.
Commercial manufacturing- CAPA should be used and the effectiveness of the actions should be evaluated.
Product discontinuation- CAPA should continue after the product is discontinued. The impact on product remaining on the market should be considered as well as other products which might be impacted.
CAPA closure and verification: [20] [21] [30]
The department head has to prove that the suggested CAPA and related activities have been finished and put into effect. QA will verify and validate the implementation and completion of CAPA by reviewing the supporting documentation. Any proposed changes due to CAPA must be made using the SOP (Standard Operating Procedure) on change control reference, which must be included in the CAPA format. The CAPA form must be used for all change control, deviations, errors, and incident reports that result in CAPA. The CAPA form must be used for all facility improvements, capital purchase requirements, significant modifications to the quality system, and compliance with regulatory requirements that give rise to CAPA. Every CAPA’s record needs to be maintained. The concerned department head will receive a copy of the completed CAPA from QA. During the management review meeting, QA will gather the CAPA data and present the overview to management. Periodically, during management review meetings, management will examine and confirm the same. CAPA-related data and records from internal audits, external/customer audits, and regulatory inspections are regarded as confidential and can only be made available for regulatory review with the director technical and QA head’s approval.
CONCLUSION:
CAPA is essential to the maintenance and enhancement of the pharmaceutical quality management system. It offers an organized approach to recognize issues, examine into their root causes, and put in place efficient preventative and remedial actions. CAPA enhances product quality, patient safety, and operational efficiency in addition to supporting companies in meeting regulatory standards including FDA, ISO, and ICH guidelines. CAPA reduces recurrent errors and promotes ongoing organizational improvement through appropriate documentation, risk assessment, root cause analysis, and ongoing monitoring. Thus, achieving quality perfection and ensuring reliable pharmaceutical production processes depend on an efficient CAPA system.
REFERENCES
Tejal Gorfad*, Nidhi Chauhan, Meghal Mehta, Rana Hani, A Review of Role of CAPA in Pharmaceutical Quality Management System, Int. J. Med. Pharm. Sci., 2026, 2 (9), 325-334. https://doi.org/10.5281/zenodo.22794782
10.5281/zenodo.22794782